American University is evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patient
University of Michigan Rogel Cancer Center is starting a new clinical trial of Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients.
This project's overall goal is to test the feasibility, acceptability and efficacy of two coach-assisted, computer-based, cognitive- behavioral therapy (C-CBT) interventions in treating depression and anxiety in adolescent and young adult cancer survivors. The two coach-assisted interventions will be compared to the standard C-CBT intervention.
The clinical trial started in November 30, 2020 and will continue throughout February 2022.
Percentage of participants who confirm acceptability of the intervention during interviews will be primary outcome measure. Participants will be interviewed about their perceptions regarding the delivery format, treatment content, and other treatment related factors. Qualitative interviews will be transcribed by research staff and coded using thematic content analysis and axial coding. Qualitative data will be reviewed iteratively until saturation is reached, that is when no new information seems to emerge during coding. Emergence or non-emergence of acceptability theme will be assessed. Findings will be descriptive and will include the percentage of participants who confirm acceptability.
The inclusion parameters are:
- Cancer survivor, either receiving active treatment or completed cancer treatment
- Experiencing depression and anxiety as measured by PHQ-9 or GAD-7
The contacts and locations are the University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04773197
